Literature DB >> 30623386

Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017.

Aishwarya Vijay1, Joseph S Ross2,3,4, Nilay D Shah5,6, Molly M Jeffery5,6, Sanket S Dhruva7,8.   

Abstract

Year:  2019        PMID： 30623386      PMCID： PMC6445908          DOI： 10.1007/s11606-018-4752-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  3 in total

1.  Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study.

Authors:  Tara Gomes; Simon Greaves; Wim van den Brink; Tony Antoniou; Muhammad M Mamdani; J Michael Paterson; Diana Martins; David N Juurlink
Journal:  Ann Intern Med       Date:  2018-08-21       Impact factor: 25.391

2.  Medicare Formulary Coverage Restrictions for Prescription Opioids, 2006 to 2015.

Authors:  Elizabeth A Samuels; Joseph S Ross; Sanket S Dhruva
Journal:  Ann Intern Med       Date:  2017-10-10       Impact factor: 25.391

3.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Elizabeth Crane; Jinhee Lee; Christopher M Jones
Journal:  Ann Intern Med       Date:  2017-08-01       Impact factor: 25.391
  3 in total
  1 in total

1.  Trends in Co-Prescribing of Opioids and Opioid Potentiators Among U.S. Adults, 2007-2018.

Authors:  Taeho Greg Rhee; Donovan T Maust; David A Fiellin; Mark Olfson
Journal:  Am J Prev Med       Date:  2020-11-13       Impact factor: 5.043
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.